Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Jussi Nurmi is active.

Publication


Featured researches published by Jussi Nurmi.


Clinical Biochemistry | 2003

A homogeneous high-throughput genotyping method based on competitive hybridization

Minna Kiviniemi; Jussi Nurmi; H. Turpeinen; Timo Lövgren; Jorma Ilonen

OBJECTIVES A reliable high-throughput assay system is necessary for the analysis of the ever-increasing numbers of single-nucleotide polymorphisms (SNP) relevant to genetic screening studies. We describe an assay suitable also for large-scale screening programs. DESIGN AND METHODS The one-step assay is based on asymmetric PCR amplification of the target sequence and subsequent time-resolved fluorescence measurement. Asymmetric amplification results in a single-stranded PCR product that is detected in the amplification vessel with a highly sensitive, homogeneous hybridization method. RESULTS A dual label, homogeneous high-throughput platform for nucleic acid sequence analysis was developed and validated using a C/T single-nucleotide polymorphism in the insulin gene as a model analyte and applied also to two other SNP-assays (poliovirus receptor A/G-polymorphism and CD86-gene exon 2 A/G-polymorphism). CONCLUSIONS The described high-throughput genotyping technology is very competitive in price, simple in design and easily applied to any analyte sequence.


International Journal of Food Microbiology | 2008

An 8-hour system for Salmonella detection with immunomagnetic separation and homogeneous time-resolved fluorescence PCR

Virve Hagren; Piia von Lode; Anniina Syrjälä; Teemu Korpimäki; Mika Tuomola; Otto Kauko; Jussi Nurmi

We describe a system consisting of rapid sample enrichment and homogeneous end-point PCR analysis that enables the detection of Salmonella in various food matrices in 8 h. Sample preparation starts with 6 h enrichment step in supplemented broth, after which Salmonella cells are collected with immunomagnetic particles. The particles are washed and dispensed to ready-to-use PCR reaction vessels, which contain dried assay-specific reagents and an internal amplification control. PCR is performed with a novel instrument platform utilising the sensitive label technology of time-resolved fluorometry. Qualitative assay results are automatically interpreted and available in 45 min after sample addition. The overall accuracy, sensitivity and specificity of the Magda CA Salmonella system were 99.1%, 98.4% and 100.0%, respectively, based on the evaluation of 107 samples (beef, pork, poultry and ready-to-eat meals) artificially contaminated with sub-lethally injured Salmonella cells.


Analytical Biochemistry | 2008

An automated PCR platform with homogeneous time-resolved fluorescence detection and dry chemistry assay kits

Virve Hagren; Piia von Lode; Anniina Syrjälä; Tero Soukka; Timo Lövgren; Hannu Kojola; Jussi Nurmi

We have developed a novel instrument platform, GenomEra, for small-scale analysis of nucleic acids. The platform combines a rapid thermal cycler, an integrated time-resolved fluorescence measurement unit, and user-friendly software for the analysis of results. Disposable low-cost plastic reaction vessels are designed specifically for the instrument and contain all of the assay-specific reagents in dry form. The appropriate assay protocol is specified on barcodes printed under the vessels and is automatically initiated by the software. Detection is based on the use of sequence-specific probes labeled with intrinsically fluorescent europium or terbium chelates and complementary quencher probes, which enable sensitive, homogeneous closed-tube assays without the risk of carryover contamination. The detection limit of the instrument (background + 3 SD) is approximately 20 pmol/L for both chelates with a dynamic range of nearly four orders of magnitude. The functionality of the platform is demonstrated with a dual-label homogeneous polymerase chain reaction (PCR) assay for the detection of Salmonella using a Magda CA Salmonella assay kit. An internal amplification control is included in each reaction to eliminate false negative results caused by PCR inhibition. Qualitative assay results are automatically interpreted by the software and are available 45 min after sample addition.


Genome Biology | 2005

The genomics of probiotic intestinal microorganisms

Seppo Salminen; Jussi Nurmi; Miguel Gueimonde

An intestinal population of beneficial commensal microorganisms helps maintain human health, and some of these bacteria have been found to significantly reduce the risk of gut-associated disease and to alleviate disease symptoms. The genomic characterization of probiotic bacteria and other commensal intestinal bacteria that is now under way will help to deepen our understanding of their beneficial effects.


Analytical Chemistry | 2002

High-performance real-time quantitative RT-PCR using lanthanide probes and a dual-temperature hybridization assay.

Jussi Nurmi; Tiina Wikman; Matti Karp; Timo Lövgren


Nucleic Acids Research | 2000

A new label technology for the detection of specific polymerase chain reaction products in a closed tube

Jussi Nurmi; Alice Ylikoski; Tero Soukka; Matti Karp; Timo Lövgren


Diabetes Technology & Therapeutics | 2007

A High-Throughput Population Screening System for the Estimation of Genetic Risk for Type 1 Diabetes: An Application for the TEDDY (The Environmental Determinants of Diabetes in the Young) Study

Minna Kiviniemi; Robert Hermann; Jussi Nurmi; Anette-G. Ziegler; Mikael Knip; Olli Simell; Riitta Veijola; Timo Lövgren; Jorma Ilonen


Clinical Biochemistry | 2008

Quantitative real-time RT-PCR assay for PCA3.

Riina-Minna Väänänen; Maria Rissanen; Otto Kauko; Siina Junnila; Ville Väisänen; Jussi Nurmi; Kalle Alanen; Martti Nurmi; Kim Pettersson


Analytical Biochemistry | 2001

High-throughput genetic analysis using time-resolved fluorometry and closed-tube detection.

Jussi Nurmi; Minna Kiviniemi; Minna Kujanpää; Minna Sjöroos; Jorma Ilonen; Timo Lövgren


Clinical Chemistry | 2002

Simultaneous Quantification of Prostate-specific Antigen and Human Glandular Kallikrein 2 mRNA in Blood Samples from Patients with Prostate Cancer and Benign Disease

Alice Ylikoski; Kim Pettersson; Jussi Nurmi; Kerttu Irjala; Matti Karp; Hans Lilja; Timo Lövgren; Martti Nurmi

Collaboration


Dive into the Jussi Nurmi's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Martti Nurmi

Turku University Hospital

View shared research outputs
Researchain Logo
Decentralizing Knowledge